What is the expected long term growth rate for REDHILL BIOPHARMA LTD-SP ADR (RDHL)?
The expected long term growth rate for REDHILL BIOPHARMA LTD-SP ADR (RDHL) is 45.22%.
REDHILL BIOPHARMA LTD-SP ADR (RDHL) Forecast, Price Target & Analyst Ratings
NASDAQ:RDHL • US7574683014
Current stock price
0.7994 USD
-0.01 (-1.68%)
At close:
0.762 USD
-0.04 (-4.68%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for REDHILL BIOPHARMA LTD-SP ADR (RDHL).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.80 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
RDHL was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RDHL.
In the previous month the buy percentage consensus was at a similar level.
RDHL was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-09-15 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-31 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-05-28 | WBB Securities | Downgrade | Strong Buy -> Buy |
| 2021-05-18 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 61.8M -27.94% | 6.53M -89.43% | 8.043M 23.17% | 38.76M 381.91% | 51.612M 33.16% | 64.974M 25.89% | |
| EBITDA YoY % growth | -34.68M 35.88% | 14.622M 142.16% | -13.994M -195.71% | N/A | N/A | N/A | |
| EBIT YoY % growth | -42.84M 40.70% | 12.632M 129.49% | -14.613M -215.68% | -6.63M 54.63% | 2.244M 133.85% | 11.73M 422.73% | |
| Operating Margin | -69.32% | 193.45% | -181.69% | -17.11% | 4.35% | 18.05% | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
45.22%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A